Orange, CA, United States of America

Saghar Mozaffari

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chapman University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saghar Mozaffari. Retrieved from https://idiyas.com/inventor/saghar-mozaffari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Saghar Mozaffari: Innovator in Targeted Drug Delivery Systems

Introduction

Saghar Mozaffari is an accomplished inventor based in Orange, California. He has made significant contributions to the field of drug delivery systems, particularly in the development of targeted peptide-drug conjugates. His innovative work aims to enhance the efficacy of chemotherapeutic agents in cancer treatment.

Latest Patents

Mozaffari holds 1 patent for his invention titled "Targeted peptide-drug conjugates." This patent describes drug delivery systems that combine a peptide targeting agent with a pharmaceutical agent. The systems are designed to improve the delivery of chemotherapeutic agents, thereby providing new methods for treating cancer.

Career Highlights

Mozaffari is affiliated with Chapman University, where he continues to advance his research in drug delivery technologies. His work is pivotal in bridging the gap between basic research and clinical applications, making a significant impact in the medical field.

Collaborations

Mozaffari collaborates with notable colleagues, including Parvin Mahdipoor and Keykavous Parang. These partnerships enhance the research environment and foster innovation in their respective fields.

Conclusion

Saghar Mozaffari's contributions to targeted drug delivery systems exemplify the importance of innovation in cancer treatment. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…